CV:
Daniel R. Matlis is Founder and President of Axendia, an analyst and strategic advisory firm providing trusted advice to executive in the Pharmaceutical, Medical Device, Diagnostics, Biotechnology and Healthcare industries.
Dan has almost three decades of industry experience spanning the Health-Science value chain. He has been involved in projects spanning R&D, clinical, manufacturing, regulatory compliance, business development and information technology.
He has been an active member in FDA’s Case for Quality Initiative since 2014 and has presented Axendia’s research findings to industry executives and the FDA officials.
Dan began his career at Johnson & Johnson, where he provided leadership in the areas of technology, regulatory compliance and business. Before founding Axendia, Dan was a Partner, VP and General Manager at a leading Life-Science consultancy firm.
He is a frequent lecturer at Industry events and has published numerous research reports and articles on key issues facing the Life-Sciences and Healthcare industries.
&nsbp;
